FDA allows injections, reduced dose of COVID monoclonal antibody therapy
By
Alicia Lasek
Jun 08, 2021
An effective but arguably underused COVID-19 monoclonal antibody therapy now may be more accessible for long-term care facilities that aren’t equipped to deliver intravenous infusions.
Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
CDC: Seniors’ comparative rate of hospitalization spiked during omicron wave
By
Alicia Lasek
Aug 26, 2022
Rates of hospitalization among seniors rose higher in comparison to younger adults during the BA.2 wave, with vaccinations providing less protection, new data show.
Contested insulin therapy remains common in nursing homes: study
By
Alicia Lasek
Apr 01, 2022
Despite being discouraged in the elderly, a facilities study has found that sliding scale insulin therapy is used in 21% of newly admitted residents who receive the drug for type 2 diabetes and is continued...
CDC: COVID vaccines safe during pregnancy, allaying a top concern of nursing home workers
By
Alicia Lasek
Apr 28, 2021
Pregnancy concerns are cited as one of the top reasons for vaccine hesitancy among long-term care workers, but there were no obvious signs of third trimester adverse events among pregnant women who received...
Pressure injuries found in 11% of SNF stroke rehab patients: study
By
Alicia Lasek
Aug 08, 2022
Providing early care for pressure injuries during stroke rehab may help improve patients’ clinical outcomes and reduce associated costs, investigators say.
First human trial of Pfizer’s bivalent booster finds shot safe, effective
By
Alicia Lasek
Oct 14, 2022
New data from a trial in humans shows that the omicron-adapted COVID-19 booster made by Pfizer and BioNTech is safe and effective in older adults, according to the drugmakers.
Lawmakers push to keep ‘ineffective’ new opioids from market
By
Alicia Lasek
Mar 08, 2023
Congressional lawmakers have renewed efforts to give the Food and Drug Administration more power to deny drug applications for opioids that are not proven clinically superior to and lower risk than currently...
WHO: Some superbugs became more antibiotic resistant during the pandemic
By
Alicia Lasek
Dec 12, 2022
Bacteria that cause healthcare-associated bloodstream infections gained increased resistance to last-resort antibiotics, according to a new report.